acridines has been researched along with Agranulocytosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, AP; Grem, JL; Hamilton, JM; Harold, N; Jasser, GB; Kao, V; Keith, B; Monahan, BP; Pace, M; Pang, J; Quinn, MG; Takimoto, CH | 1 |
King, GW; Kraut, EH; Kuebler, JP; Moore, T; Triozzi, P | 1 |
2 trial(s) available for acridines and Agranulocytosis
Article | Year |
---|---|
A phase I pharmacologic and pharmacodynamic study of pyrazoloacridine given as a weekly 24-hour continuous intravenous infusion in adult cancer patients.
Topics: Acridines; Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Apoptosis; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Pyrazoles | 2002 |
Phase II study of pyrazoloacridine in metastatic renal cell carcinoma.
Topics: Acridines; Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Evaluation; Humans; Kidney Neoplasms; Lung Neoplasms; Middle Aged; Nausea; Pyrazoles; Thrombocytopenia; Vomiting | 2001 |